Results 121 to 130 of about 22,696 (353)
Studies on the fate of pulmonary surfactant in the lung [PDF]
R Desai+4 more
openalex +1 more source
CXCR1 Depletion in Ly6C+ cDC2 Alleviates Acute Lung Injury via Modulation of Th17/Treg Balance
Pro‐inflammatory Ly6C⁺ cDC2s are identified as key effector cells mediating Cxcr1 signaling, driving the progression of ALI. Ly6C⁺ cDC2s release high levels of Il‐6 and Il‐1β, inducing Th17 differentiation. Cxcr1 deficiency reduces Il‐6 and Il‐1β production from Ly6C⁺ cDC2s through suppressing MEK1/ERK /NF‐κB signaling, thereby shifts naïve T cells ...
Shenghui Li+8 more
wiley +1 more source
Bronchopulmonary dysplasia: an old and new disease
Bronchopulmonary dysplasia (BPD) is one of the most common and significant medical complications associated with prematurity. It is made more serious by its morbidity and mortality rates.
Caterina Franco+2 more
doaj +1 more source
Augmentation of Pulmonary Surfactant Secretion by Lung Expansion at Birth [PDF]
Edward E. Lawson+3 more
openalex +1 more source
The G‐CS/MSN drug delivery system enhances intervertebral disc repair through sequential drug release. Abstract Intervertebral disc degeneration (IDD) is characterized by an inflammatory environment and dysregulation of the extracellular matrix metabolism (ECM).
Xiangzhen Kong+12 more
wiley +1 more source
Effect of Aminophyllin and Dexamethasone on Secretion of Pulmonary Surfactant in Fetal Rabbits [PDF]
Anthony Corbet+3 more
openalex +1 more source
Engineered Anti‐Senescence Trachea With Post‐Transplanted Regenerative Homeostasis
Bioengineered trachea undergoes post‐transplanted senescence, which is found in this study for the first time. Hebe‐ET is designed with dual anti‐senescence strategies: fiber‐film scaffold in cartilage rings for close‐packed cell interaction, and quercetin‐loaded fibrous rings for immune modulation.
Ziyin Pan+14 more
wiley +1 more source
This study presents a binary tumor‐microenvironment‐on‐a‐chip (T‐MOC) system incorporating multicellular tumor spheroids (MCTs) as an alternative preclinical platform to evaluate the efficacy of anticancer natural products. The T‐MOC model reproduces in vivo drug delivery barriers and physiological conditions, enabling morphological analysis to predict
Youngwon Kim+7 more
wiley +1 more source
Pulmonary Surfactants: a New Therapeutic Target in Asthma. [PDF]
Choi Y, Jang J, Park HS.
europepmc +1 more source